Presentations & Interviews
Earnings presentations and investor-related interviews
Marrone Bio Innovations CEO stepping down from bio-agriculture company she founded
Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone tells Proactive she's retiring as CEO of the Davis, California-based bio-protection and plant health company she founded. Marrone, who…
Proactive Investor Interview: Marrone Bio Innovations grows revenue to $7M in 3Q
Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone tells Proactive the bioprotection and plant health company posted third-quarter results that saw revenue jump 28% year-over-year on the back…
Webcast: Pam Marrone Presentation at MicroCap Rodeo Investor Conference
MicroCap Rodeo: Marrone Bio Innovations Inc Tuesday, October 15, 2019 10:55 AM Central Time Login Required on Webcast Page Here
Proactive: Marrone Bio Innovations performing well in all areas with strong 2Q results
Marrone Bio Innovations Inc (NASDAQ:MBII) CFO Jim Boyd tells Proactive the sustainable bio-protection and plant health solutions company posted strong second quarter results, and explains how its…
Marrone Bio Innovations is bringing biological pesticides to the pest management industry
Proactive Investors | Andrew Kessel | Article Link | August, 2019 Marrone's products are made from naturally-occurring substances like bacteria or plant extracts Biopesticides used in conjunction…
Update with Marrone Bio Innovations, Inc. (NASDAQ: MBII) – | Stock News Now
SNNLive spoke with Jim Boyd, President and CFO of Marrone Bio Innovations, Inc. (NASDAQ: MBII) at the LD Micro Invitational 2019 in Bel Air, CA.
Proactive Investor Interview: Marrone Bio Innovations signs deal to collaborate with Compass Minerals Plant Nutrition
Marrone Bio Innovations (Nasdaq:MBII) CEO DR Pamela Marrone joined Steve Darling from Proactive Investors in our New York studio to talk about a deal Compass Minerals Plant Nutrition.
National Securities Initiates Coverage of MBII
Download the report: MBII Initiation, National Securities January 23, 2019 Marrone Bio Innovations BUY (MBII, $1.31) Bucking The Trend: Buy Opportunity For High Growth Business In Sluggish…